Atlas Trials

Probiotic Supplementation Reduces Gastrointestinal Symptoms During the Therapy and Improves Therapeutic Response in AL Amyloidosis

Clinical trial NCT05776940 · UNKNOWN

Trial details

NCT number
NCT05776940
Sponsor
Air Force Military Medical University, China
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Immunoglobulin Light-chain Amyloidosis
Start date
2023-03-31
Primary completion
2026-03-31
Enrollment
116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.